Publication
XEN® Implant and Trabeculectomy Medium-Term Quality of Life Assessment and Comparison of Results
| dc.contributor.author | Basílio, AL | |
| dc.contributor.author | Moura-Coelho, N | |
| dc.contributor.author | Passos, I | |
| dc.contributor.author | Sá Cardoso, M | |
| dc.contributor.author | Domingues, I | |
| dc.contributor.author | Reina, M | |
| dc.contributor.author | Flores, R | |
| dc.contributor.author | Gomes, T | |
| dc.date.accessioned | 2019-11-21T16:35:07Z | |
| dc.date.available | 2019-11-21T16:35:07Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | AIM: To evaluate and compare the quality of life of patients submitted to XEN® implant or trabeculectomy and the relationship with potentially involved variables. METHODS: A cross-sectional study of patients with advanced open-angle glaucoma who underwent implantation of XEN® (group 1) and trabeculectomy (group 2) between October 2015 and February 2017. The studied variables were: age, gender, follow-up time, need of topical anti-hypertensive therapy, visual acuity and intraocular pressure (IOP). The quantification of the quality of life was attained through the Glaucoma Symptom Scale (GSS) questionnaire. RESULTS: Totally 34 eyes (34 patients) were included, 17 in each group. The mean GSS scores for group 1 were 42.6±6.8 (median, 47; p25, 36.5; p75, 48.5) and for group 2 it was 41.6±7.0 (median, 43; p25, 36.5; p75, 47.0; P=0.34). There was a strong negative correlation between the need for topical anti-hypertensive drugs and the GSS result in both groups (r=-0.88, P<0.01, r=-0.59, P=0.01, respectively) and a moderate negative correlation with IOP in group 1 (r=-0.50, P=0.03). CONCLUSION: The analysis demonstrates the non-inferiority of medium-term quality of life of one group in relation to the other (XEN® implant and trabeculectomy). The number of topical anti-hypertensive drugs and IOP negatively influenced the quality of life. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Int J Ophthalmol. 2018 Dec 18;11(12):1941-1944. | pt_PT |
| dc.identifier.doi | 10.18240/ijo.2018.12.11 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.17/3360 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Press of International Journal of Ophthalmology | pt_PT |
| dc.subject | CHLC OFT | pt_PT |
| dc.subject | Quality of Life | pt_PT |
| dc.subject | Trabeculectomy | pt_PT |
| dc.title | XEN® Implant and Trabeculectomy Medium-Term Quality of Life Assessment and Comparison of Results | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 1944 | pt_PT |
| oaire.citation.issue | 12 | pt_PT |
| oaire.citation.startPage | 1941 | pt_PT |
| oaire.citation.title | International Journal of Ophthalmology | pt_PT |
| oaire.citation.volume | 11 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |